EP1005862A1 — Anti-chlamydia agents
Assigned to Mitsui Norin Co Ltd · Expires 2000-06-07 · 26y expired
What this patent protects
Anti-Chlamydia agents characterized by containing tea polyphenol; and a method for preventing or treating Chlamydia infection characterized by administering a composition containing a therapeutically efficacious amount of tea polyphenol to the affected part of a patient. The tea …
USPTO Abstract
Anti-Chlamydia agents characterized by containing tea polyphenol; and a method for preventing or treating Chlamydia infection characterized by administering a composition containing a therapeutically efficacious amount of tea polyphenol to the affected part of a patient. The tea polyphenol to be used herein is a component of tea which is a natural product having been widely taken as a drink from ancient times. Thus, tea suffers no problem in safety. Therefore, the tea polyphenol also has no harmful side effect on the human body and is free from any fear of the appearance of a resistant strain.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.